Boai NKY Medical Holdings (SZSE:300109) - Prezzo delle azioni, notizie e analisi

300109 Panoramica delle azioni

Boai NKY Medical Holdings Ltd. opera nel settore della chimica fine e dell'assistenza medica in Cina e a livello internazionale. Maggiori dettagli

300109 analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	3/6
Salute finanziaria	6/6
Dividendi	4/6

Premi

Il rapporto prezzo/utile ( 18.6 x) è inferiore al mercato CN ( 35.3 x)

Analisi del rischio

Il dividendo di 4.35% non è ben coperto dai flussi di cassa liberi

Gli azionisti sono stati diluiti nell'ultimo anno

Boai NKY Medical Holdings Ltd. Concorrenti

Shandong Yanggu Huatai Chemical

SZSE:300121

CN¥6.3b

Fujian Yuanli Active CarbonLtd

SZSE:300174

CN¥6.8b

Jiangyin Jianghua Microelectronics Materials

SHSE:603078

CN¥6.5b

Hubei Zhenhua ChemicalLtd

SHSE:603067

CN¥6.7b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Boai NKY Medical Holdings
Prezzi storici delle azioni
Prezzo attuale dell'azione	CN¥15.32
Massimo di 52 settimane	CN¥16.32
Minimo di 52 settimane	CN¥8.02
Beta	0.11
1Variazione di 1 mese	17.94%
Variazione a 3 mesi	42.12%
Variazione di 1 anno	16.06%
3Variazione a 3 anni	0.087%
Variazione a 5 anni	18.88%
Variazione dall'IPO	45.39%

Notizie e aggiornamenti recenti

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

Oct 31

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Oct 08

Recent updates

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

Oct 31

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Oct 08

Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares

Aug 23

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Jul 25

Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year

Jun 04

We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)

May 27

Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?

Apr 03

Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company

Mar 04

Rendimenti per gli azionisti

	300109	CN Chemicals	CN Mercato
7D	11.3%	-3.5%	-4.1%
1Y	16.1%	-5.2%	3.8%

Ritorno vs Industria: 300109 ha superato il CN Chemicals che ha restituito -5.2 % nell'ultimo anno.

Rendimento vs Mercato: 300109 ha superato il mercato CN che ha restituito 3.8 % nell'ultimo anno.

Volatilità dei prezzi

Is 300109's price volatile compared to industry and market?
300109 volatility
300109 Average Weekly Movement	8.7%
Chemicals Industry Average Movement	7.8%
Market Average Movement	8.2%
10% most volatile stocks in CN Market	12.6%
10% least volatile stocks in CN Market	5.6%

Prezzo delle azioni stabile: 300109 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 9% ) di 300109 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1987	1,165	Junzheng Zhang	www.boai-nky.com

Boai NKY Medical Holdings Ltd. opera nel settore della chimica fine e dell'assistenza medica in Cina e a livello internazionale. L'azienda offre prodotti della serie polivinilpirrolidone (PVP) e prodotti a base di vinilmetiletere e acido maleico; prodotti della serie copolimero di anidride (PVME/MA); GBL, 2-pirrolidone, monomero NVP, serie PVPK (povidone), copovidone e altri prodotti della serie copolimero VP/VA; PVPP (povidone reticolato), PVP-I e relativi intermedi farmaceutici.

Boai NKY Medical Holdings Ltd. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Boai NKY Medical Holdings con la sua capitalizzazione di mercato?
300109 statistiche fondamentali
Capitalizzazione di mercato	CN¥7.43b
Guadagni(TTM)	CN¥399.35m
Ricavi(TTM)	CN¥1.49b

18.6x

Rapporto P/E

5.0x

Rapporto P/S

300109 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
300109 Conto economico (TTM)
Ricavi	CN¥1.49b
Costo del fatturato	CN¥737.63m
Profitto lordo	CN¥750.25m
Altre spese	CN¥350.90m
Guadagni	CN¥399.35m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	0.82
Margine lordo	50.42%
Margine di profitto netto	26.84%
Rapporto debito/patrimonio netto	11.6%

Come si è comportato 300109 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

4.4%

Rendimento attuale del dividendo

77%

Rapporto di remunerazione

300109 Panoramica delle azioni

Premi

Analisi del rischio

Boai NKY Medical Holdings Ltd. Concorrenti

SZSE:300121

CN¥6.3b

SZSE:300174

CN¥6.8b

SHSE:603078

CN¥6.5b

SHSE:603067

CN¥6.7b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Less than half of directors are independent

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.30 in 3Q 2023)

Investor sentiment deteriorates as stock falls 20%

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Recent updates

Less than half of directors are independent

We Think That There Are More Issues For Boai NKY Medical Holdings (SZSE:300109) Than Just Sluggish Earnings

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.30 in 3Q 2023)

Investor sentiment deteriorates as stock falls 20%

Market Might Still Lack Some Conviction On Boai NKY Medical Holdings Ltd. (SZSE:300109) Even After 40% Share Price Boost

Boai NKY Medical Holdings Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 22%

Now 26% overvalued

Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.29 in 2Q 2023)

Boai NKY Medical Holdings Ltd. (SZSE:300109) Doing What It Can To Lift Shares

Does Boai NKY Medical Holdings (SZSE:300109) Have A Healthy Balance Sheet?

Boai NKY Medical Holdings Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Boai NKY Medical Holdings (SZSE:300109) Is Paying Out A Larger Dividend Than Last Year

Dividend increased to CN¥1.00

Boai NKY Medical Holdings Ltd. Announces Implementation of Final A Share Cash Dividend for 2023, Payable on 07 June 2024

We Like These Underlying Return On Capital Trends At Boai NKY Medical Holdings (SZSE:300109)

Boai NKY Medical Holdings Ltd. Approves Cash Dividend for the Year 2023

Boai NKY Medical Holdings Ltd., Annual General Meeting, May 23, 2024

First quarter 2024 earnings released: EPS: CN¥0.38 (vs CN¥0.39 in 1Q 2023)

Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023

Should You Be Adding Boai NKY Medical Holdings (SZSE:300109) To Your Watchlist Today?

Now 23% overvalued after recent price rise

Boai NKY Medical Holdings Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Boai NKY Medical Holdings Ltd. (SZSE:300109) Stock Rockets 39% But Many Are Still Ignoring The Company

Full year 2023 earnings released: EPS: CN¥1.63 (vs CN¥0.88 in FY 2022)

Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding

Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding

Investor sentiment deteriorates as stock falls 20%

Boai NKY Medical Holdings Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.42 in 3Q 2022)

Boai NKY Medical Holdings Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.34 in 2Q 2022)

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 30, 2023

Boai NKY Medical Holdings Ltd. Approves Cash Dividend for 2022

First quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥0.10 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.96 (vs CN¥0.91 in FY 2021)

Investor sentiment deteriorated over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.046 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Gryningskust Holding AB acquired additional 14.0 % minority stake in NeoDynamics AB (publ) (OM:NEOD).

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022

Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022

Boai Nky Medical Holdings Ltd. Approves Cash Dividend

Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues miss analyst expectations

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Boai NKY Medical Holdings Ltd. (SZSE:300109) commences a Equity Buyback Plan under the authorization approved on December 21, 2021.

Third quarter 2021 earnings released: EPS CN¥0.046 (vs CN¥0.08 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.067 (vs CN¥0.12 in 2Q 2020)

Abcam plc (AIM:ABC) entered into a definitive agreement to acquire BioVision, Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for approximately $340 million.

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Shanghai Haitong Securities Assets Management Co.,Ltd. completed the acquisition of 3% stake in Boai NKY Medical Holdings Ltd. (SZSE:300109) from Wang Donghu.

Boai Nky Medical Holdings Ltd. Approves Final Cash Dividend for 2020